Significance of the Tumor Microenvironment in Liver Cancer Progression
- PMID: 32865906
- DOI: 10.1615/CritRevOncog.2020034987
Significance of the Tumor Microenvironment in Liver Cancer Progression
Abstract
The tumor microenvironment (TME) favors the complex interaction of tumor cells with stromal cells that are recognized to be the regulators of hallmarks of liver cancer growth and metastasis. The most common components of TME include cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and tumor-associated extracellular matrix (ECM) are involved in facilitating the enhancement of liver cancer and can be exploited as potential targets. In addition, cancer stem cells (CSCs) that are known to regulate tumor initiation and progression are present in the TME. All these accumulated factors of the TME represent the driving force for liver cancer progression. This review is focused on the functions of each of the above-mentioned components of the TME and their roles as potential key players in targeting liver cancer.
Similar articles
-
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1. Mol Cancer. 2021. PMID: 34635121 Free PMC article. Review.
-
Cancer associated-fibroblast-derived exosomes in cancer progression.Mol Cancer. 2021 Dec 1;20(1):154. doi: 10.1186/s12943-021-01463-y. Mol Cancer. 2021. PMID: 34852849 Free PMC article. Review.
-
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13. OMICS. 2020. PMID: 32176591 Review.
-
Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?Eur J Pharmacol. 2022 Aug 5;928:175087. doi: 10.1016/j.ejphar.2022.175087. Epub 2022 Jun 6. Eur J Pharmacol. 2022. PMID: 35679891 Review.
-
Cancer-associated fibroblasts in hepatocellular carcinoma.World J Gastroenterol. 2016 Aug 14;22(30):6841-50. doi: 10.3748/wjg.v22.i30.6841. World J Gastroenterol. 2016. PMID: 27570421 Free PMC article. Review.
Cited by
-
Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm.J Oncol. 2022 Sep 15;2022:2469592. doi: 10.1155/2022/2469592. eCollection 2022. J Oncol. 2022. PMID: 36157238 Free PMC article.
-
Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.Appl Bionics Biomech. 2022 Jan 28;2022:8926221. doi: 10.1155/2022/8926221. eCollection 2022. Appl Bionics Biomech. 2022. Retraction in: Appl Bionics Biomech. 2023 Nov 1;2023:9862929. doi: 10.1155/2023/9862929. PMID: 35126665 Free PMC article. Retracted.
-
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.Front Immunol. 2021 Nov 26;12:783236. doi: 10.3389/fimmu.2021.783236. eCollection 2021. Front Immunol. 2021. PMID: 34899747 Free PMC article. Review.
-
Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy.Sci Rep. 2023 Nov 26;13(1):20770. doi: 10.1038/s41598-023-48073-w. Sci Rep. 2023. PMID: 38008819 Free PMC article.
-
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model.Biomark Res. 2024 Oct 14;12(1):122. doi: 10.1186/s40364-024-00660-3. Biomark Res. 2024. PMID: 39402682 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical